Related Experiment Video
Updated: Oct 17, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Vaccine coverage in children, adolescents and adults with type 1 diabetes and their close contacts in Crete
Victoria Giatraki1, Helen Dimitriou1, Aggelos Pappas2
1Department of Pediatrics, University Hospital of Heraklion, Medical School University of Crete, Greece.
Insights
Type 1 diabetes patients show good adherence to routine childhood vaccines but lower rates for adolescent and specific vaccines. Influenza vaccination is insufficient for both patients and their close contacts, indicating a need for targeted interventions.
Area of Science:
- Immunology
- Endocrinology
- Public Health
Background:
- Individuals with type 1 diabetes (T1D) face heightened risks of infections from vaccine-preventable diseases.
- Assessing vaccination compliance in T1D patients and their contacts is crucial for public health strategies.
Purpose of the Study:
- To evaluate vaccination coverage among T1D patients (children, adolescents, and adults) and their close contacts.
- To identify factors influencing vaccination adherence and deviations from recommended schedules.
Main Methods:
- Retrospective analysis of vaccination records, medical files, and telephone interviews from 258 T1D patients.
- Assessment of demographic parameters, glycemic control, and influenza vaccination status of 605 close contacts.
Main Results:
- High coverage for routine childhood vaccines (e.g., PCV, Hib, MMR), but lower rates for adolescent/group-specific vaccines (e.g., HPV, meningococcus ACWY, 23-valent pneumococcal).
- Influenza vaccination coverage was 76.7% in children and 64.4% in adults; approximately 50% of close contacts remained unvaccinated.
- Better glycemic control correlated with higher adherence to vaccination schedules and a more vaccinated family environment.
Conclusions:
- While routine childhood vaccination is adequate, T1D patients require improved coverage for adolescent and specific vaccines.
- Influenza vaccination rates are suboptimal for both T1D individuals and their close contacts.
- Targeted interventions are necessary to enhance overall vaccination uptake in this vulnerable population.
Background:
Individuals with type 1 diabetes (T1D) are at increased risk of infections from vaccine-preventable diseases. This study focuses on compliance of T1D patients to the recommended vaccination schedule, vaccination of their close contacts for influenza and on factors potentially contributing to vaccination program deviations.
Methods:
The study population comprised children, adolescents and adults with T1D under follow-up at the Department of Pediatrics University Hospital and the Diabetic Center General Hospital, Heraklion, Crete-Greece. Data were extracted, following informed consent, from individual's vaccination booklet, medical files and telephone interview. Vaccination records, demographic parameters, glycemic control and influenza vaccination of close contacts were assessed.
Results:
The study included 258 participants (111 children/adolescents, 147 adults). Vaccination coverage for influenza was 76.7% for children, 64.4% for adults, for PCV 90.9% for children, but only 10.8% for the 23-valent, for hepatitis B 99% for children and 78.2% for adults. Youngsters were vaccinated against Hib 91.9%, meningococcus C 98.2%, measles-mumps-rubella 90.3%, chickenpox 86.4%, hepatitis A 76.5% and HPV 42.5%. Less than 65% of all individuals were fully vaccinated for diphtheria-tetanus-pertussis and meningococcus ACWY. Approximately 50% of the 605 close contacts were not vaccinated against influenza. Individuals with better glycemic status seemed to adhere to the recommended schedule and had a better vaccinated family environment.
Conclusions:
Vaccination coverage for T1D individuals was sufficient regarding the majority of routine childhood vaccines, but less for adolescence and group-specific vaccines. Their family contacts were not sufficiently vaccinated for influenza. Targeted interventions are required in order to increase vaccination rates.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Vaccinations
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

